HB4640

Summary

A West Virginia bill adding FDA-approved crystalline polymorph psilocybin to the state's drug scheduling framework is on its first reading in the House. Scheduling FDA-approved crystalline polymorph psilocybin would establish a legal framework governing how this compound may be dispensed or accessed in West Virginia.

More West Virginia Cannabis Bills

• SB906Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendationsPassed
• HB5074Relating to changing the allocation of proceeds in the Medical Cannabis Program Fund.Vetoed
• HB5260Relating generally to medical cannabisIn Committee
• HB5658Compassionate Access to Medical Cannabis Act or Ryan’s Law.Introduced
• HB5588Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD)Introduced
• SB892Modifying allowable forms of medical cannabis to include edible formIntroduced
• SB808Regulating consumable hemp productsIntroduced
• SB809Rescheduling cannabis from Schedule 1 to Schedule 3Introduced
• HJR37Amending Constitution to allow for possession, manufacture and sale of cannabisIntroduced
• HB5259Relating to the cultivation of medical cannabisIntroduced
• HB5188Authorizing possession and smoking of medical cannabis by approved personsIntroduced
• HB5100Transferring all regulatory and enforcement responsibilities for CBD and Kratom from the Department of Agriculture to the Alcohol Beverage Control Administration.Introduced